Safety and Efficacy of PG101 for Dry Eye Syndrome
Clinical trial NCT02078661 · COMPLETED
Trial details
- NCT number
- NCT02078661
- Sponsor
- Rhodes Pharmaceuticals, L.P.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-01-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.